HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,934,520 | +5.9% | 338,600 | 0.0% | 0.03% | +12.0% |
| Q2 2023 | $12,213,302 | +613.5% | 338,600 | +655.5% | 0.02% | +525.0% |
| Q1 2023 | $1,711,676 | -30.3% | 44,820 | +3.8% | 0.00% | -33.3% |
| Q4 2022 | $2,456,373 | +46.0% | 43,170 | +1.4% | 0.01% | +50.0% |
| Q3 2022 | $1,683,000 | -10.1% | 42,570 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,873,000 | +1.8% | 42,570 | -7.7% | 0.00% | 0.0% |
| Q1 2022 | $1,840,000 | -0.8% | 46,134 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,855,000 | -77.5% | 46,134 | -77.3% | 0.00% | -76.5% |
| Q3 2021 | $8,260,000 | +18.6% | 203,043 | +32.4% | 0.02% | +21.4% |
| Q2 2021 | $6,962,000 | +8.9% | 153,311 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $6,392,000 | +5.2% | 153,311 | +7.7% | 0.01% | 0.0% |
| Q4 2020 | $6,078,000 | +339.5% | 142,305 | +170.5% | 0.01% | +366.7% |
| Q3 2020 | $1,383,000 | +478.7% | 52,605 | +489.5% | 0.00% | +200.0% |
| Q2 2020 | $239,000 | +48.4% | 8,923 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $161,000 | -49.1% | 8,923 | -50.0% | 0.00% | 0.0% |
| Q4 2019 | $316,000 | – | 17,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |